Journal of Shandong University (Health Sciences) ›› 2019, Vol. 57 ›› Issue (5): 116-120.doi: 10.6040/j.issn.1671-7554.0.2019.0148

Previous Articles    

Expression and significance of microRNA-141 in granulosa cells of patients with polycystic ovary syndrome

HE Tingting1, LIU Hong1, SHU Kaiyun1, SONG Xiaocui2, SHI Yuhua1   

  1. 1. Center for Reproductive Medicine, Shandong University;
    National Research Center for Assisted Reproductive Technology and Reproductive Genetics;
    Key Laboratory for Reproductive Endocrinology(Shandong University), Ministry of Education;
    Shandong Provincial Key Laboratory of Reproductive Medicine;
    Shandong Provincial Clinical Medicine Research Center for Reproductive Health, Jinan 250001, Shandong, China;
    2. Department of Reproductive Medicine, Second Hospital of Shandong University, Jinan 250033, Shandong, China
  • Published:2022-09-27

PDF (PC)

72

Abstract: Objective To investigate the expression of microRNA-141(miR-141)in ovarian granulosa cells of patients with polycystic ovary syndrome(PCOS)and its clinical significance. Methods A total of 70 PCOS patients were divided into normal-BMI group(BMI<25, n=42) and obesity group(BMI≥25, n=28)according to their(BMI), and 71 controls were divided into normal-BMI group(BMI<25, n=60)and obesity group(BMI≥25, n=11). The expression of miR-141 in ovarian granulosa cells of each group was detected with real-time quantitative reverse transcription PCR(qRT-PCR), and its clinical significance was analyzed. Results The expression of miR-141 was higher in the normal-BMI PCOS group than in the normal-BMI control group (P<0.001); and compared with obesity control group, higher expression of miR-141 was observed in obesity PCOS group (P=0.009). In addition, the incidence of 山 东 大 学 学 报 (医 学 版)57卷5期 -贺婷婷,等.多囊卵巢综合征患者颗粒细胞中microRNA-141的表达与意义 \=-pregnancy complications in PCOS patients tended to be higher, but there was no statistical significance(P>0.0125). Conclusion The expression of miR-141 is higher in the PCOS groups than in the control groups. and the risk of pregnancy complications tends to increase in PCOS patients, suggesting that miR-141 may play an important role in the pathogenesis of PCOS.

Key words: Polycystic ovary syndrome, Granulosa cell, MicroRNA-141, Pregnancy complications

CLC Number: 

  • R711.75
[1] Goodarzi MO, Dumesic DA, Chazenbalk G, et al. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis[J]. Nat Rev Endocrinol, 2011, 7(4):219-231.
[2] Livadas S, Diamanti-Kandarakis E. Polycystic ovary syndrome: definitions, phenotypes and diagnostic approach[J]. Front Horm Res, 2013, 40: 1-21. doi:10.1159/000341673.
[3] Shi Y, Zhao H, Shi Y, et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome[J]. Nat Genet, 2012, 44(9):1020-1025.
[4] Zhang W, Wei D, Sun X, et al. Family-based analysis of adiponectin gene polymorphisms in Chinese Han polycystic ovary syndrome[J]. Fertil Steril, 2014, 101(5):1419-1423.
[5] Yates LA, Norbury CJ, Gilbert RJ. The long and short of microRNA[J]. Cell, 2013, 153(3):516-519.
[6] Guo D, Jiang H, Chen YQ, et al. Elevated microRNA-141-3p in placenta of non-diabetic macrosomia regulate trophoblast proliferation[J]. EBioMedicine, 2018, 38: 154-161. doi:10.1016/j.ebiom.2018.11.002.
[7] Li D, Xu D, Xu Y, et al. MicroRNA-141-3p targets DAPK1 and inhibits apoptosis in rat ovarian granulosa cells[J]. Cell Biochem Funct, 2017, 35(4):197-201.
[8] Apovian CM. Obesity: definition, comorbidities, causes, and burden[J]. Am J Manag Care, 2016, 22(7 Suppl):s176-185.
[9] 夏雅仙. 多囊卵巢综合征( PCOS)诊断—中华人民共和国卫生行业标准[C]. 2012 浙江省计划生育与生殖医学学术年会论文集, 2012: 130-137.
[10] Kaur S, Archer KJ, Devi MG, et al. Differential gene expression in granulosa cells from polycystic ovary syndrome patients with and without insulin resistance: identification of susceptibility gene sets through network analysis[J]. J Clin Endocrinol Metab, 2012, 97(10): E2016-E2021.
[11] Hammond SM. An overview of microRNAs[J]. Adv Drug Deliv Rev, 2015, 87: 3-14. doi:10.1016/j.addr.2015.05.001.
[12] Mohr AM, Mott JL. Overview of microRNA biology[J]. Semin Liver Dis, 2015, 35(1):3-11.
[13] Lee YS, Dutta A. MicroRNAs in cancer[J]. Annu Rev Pathol, 2009, 4: 199-227. doi:10.1146/annurev.pathol.4.110807.092222.
[14] Sørensen AE, Wissing ML, Salö S, et al. MicroRNAs related to polycystic ovary syndrome(PCOS)[J]. Genes(Basel), 2014, 5(3): 684-708.
[15] Acunzo M, Romano G, Wernicke D, et al. MicroRNA and cancer: a brief overview[J]. Adv Biol Regul, 2015, 57: 1-9. doi:10.1016/j.jbior.2014.09.013.
[16] Chakraborty C, Doss CG, Bandyopadhyay S, et al. Influence of miRNA in insulin signaling pathway and insulin resistance: micro-molecules with a major role in type-2 diabetes[J]. Wiley Interdiscip Rev RNA, 2014, 5(5):697-712.
[17] 贾月月, 刘洪彬, 李婧博, 等. 多囊卵巢综合征患者颗粒细胞microRNA-200b的表达及影响[J]. 山东大学学报(医学版), 2017, 55(1):63-68. JIA Yueyue, LIU Hongbin, LI Jingbo, et al. Expression of microRNA-200b in granulosa cells of PCOS [I].Journal of Shandong University(Health Sciences), 2017, 55(1): 63-68.
[18] 李婧博, 刘洪彬, 贾月月, 等. microRNA-183在PCOS胰岛素抵抗中的表达及其临床意义[J]. 山东大学学报(医学版), 2017, 55(1): 69-74. LI Jingbo, LIU Hongbin, JIA Yueyue, et al. Expression and clinical significance of microRNA-183 in polycystic ovary syndrome with insulin resistance[J]. Journal of Shandong University(Health Sciences), 2017, 55(1): 69-74.
[19] Belgardt BF, Ahmed K, Spranger M, et al. The microRNA-200 family regulates pancreatic beta cell survival in type 2 diabetes[J]. Nat Med, 2015, 21(6):619-627.
[20] Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus[J]. Fertil Steril, 2002, 77(6):1095-1105.
[21] Li T, Mo H, Chen W, et al. Role of the PI3K-Akt Signaling Pathway in the Pathogenesis of Polycystic Ovary Syndrome[J]. Reprod Sci, 2017, 24(5):646-655.
[22] Choi SK, Kim HS, Jin T, et al. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A[J]. BMC Cancer, 2016, 16:570.doi:10.1186/s12885-016-2620-7.
[23] Liu X, Gao R, Chen X, et al. Possible roles of mmu-miR-141 in the endometrium of mice in early pregnancy following embryo implantation[J]. PloS One, 2013, 8(6):e67382.doi:10.1371/journal.pone.0067382.
[24] Tang Q, Wu W, Xu X, et al. miR-141 contributes to fetal growth restriction by regulating PLAG1 expression[J]. PloS One, 2013, 8(3):e58737.doi:10.1371/journal.pone.0058737.
[25] Chim SS, Shing TK, Hung EC, et al. Detection and characterization of placental microRNAs in maternal plasma[J]. Clin Chem, 2008, 54(3):482-490.
[26] Jia Y, Yang Y, Zhan Q, et al. Inhibition of SOX17 by microRNA 141 and methylation activates the WNTsignaling pathway in esophageal cancer[J]. J Mol Diagn, 2012, 14(6):577-585.
[27] Chazenbalk G, Chen YH, Heneidi S, et al. Abnormal expression of genes involved in inflammation, lipid metabolism, and Wnt signaling in the adipose tissue of polycystic ovary syndrome[J]. J Clin Endocrinol Metab, 2012, 97(5):E765-770.
[28] Palomba S, de Wilde MA, Falbo A, et al. Pregnancy complications in women with polycystic ovary syndrome[J]. Hum Reprod Update, 2015, 21(5):575-592.
[29] Sterling L, Liu J, Okun N, et al. Pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization[J]. Fertil Steril, 2016, 105(3):791-797.e2.
[1] SONG Tian, FU Linlin, WANG Qiumin, YANG Xiao, WANG Ying, BIAN Yuehong, SHI Yuhua. Expression of fatty acid transport protein 1 in granulosa cells of patients with polycystic ovary syndrome [J]. Journal of Shandong University (Health Sciences), 2022, 60(2): 22-26.
[2] ZHANG Jianping, LUO Yinger. Application progress of anticoagulant drugs in the treatment of recurrent adverse pregnancy [J]. Journal of Shandong University (Health Sciences), 2021, 59(8): 14-19.
[3] NIU Qun, SHI Jingjing, FU Jiang. Effects of WNT5A gene on insulin reactivity and insulin resistance in granulosa cells [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 57-63.
[4] HAN Xiao, LI Lei, LIU Congcong. Effect of testosterone on the expression of polycystic ovary syndrome susceptibility gene Tox3 in zebrafish [J]. Journal of Shandong University (Health Sciences), 2021, 59(4): 42-47.
[5] GONG Xiaoshu, WU Richao, LI Xiufang, PAN Ye, WANG Ze, SHI Yuhua. Effect of different ovulation induction regimens for endometrial preparation on the outcome of frozen-thawed embryo transfer among 603 women with polycystic ovary syndrome [J]. Journal of Shandong University (Health Sciences), 2021, 59(3): 48-54.
[6] HA Lingxia, YIN Ting, WU Yangyang, LI Weixia, DU Yudong. Correlation between insulin resistance and expressions of local inflammatory factors and glucose transporter protein type-4 in the endometrium of patients with polycystic ovary syndrome [J]. Journal of Shandong University (Health Sciences), 2021, 59(11): 41-47.
[7] DING Xiangyun, YU Qingmei, ZHANG Wenfang, ZHUANG Yuan, HAO Jing. Correlation of the expression of insulin-like growth factor II in granulosa cells and ovulation induction outcomes of 84 patients with polycystic ovary syndrome [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 60-66.
[8] HE Tingting, LIU Xin, LIU Hongbin, ZHAO Shigang, ZHANG Xiuqing, LIU Qingqing, YOU Li, SHI Yuhua. Expression of Forkhead box protein O1 mRNA in granulosa cells of polycystic ovary sydrome patients and its significance [J]. Journal of Shandong University (Health Sciences), 2019, 57(2): 75-79.
[9] LIU Congcong, LIU Hongbin, FU Jiang, LI Lei. Expression of polycystic ovary syndrome susceptibility gene dennd1a in zebrafish models [J]. Journal of Shandong University (Health Sciences), 2019, 57(1): 48-54.
[10] SHU Xin, WANG Qun, HUANG Tao, ZHAO Shigang, SHI Yuhua, LIU Hongbin. Expression of FBP1 in granulosa cells of PCOS patients with hyperandrogenism and its significance [J]. Journal of Shandong University (Health Sciences), 2018, 56(4): 58-63.
[11] ZHANG Suping, WANG Ze, ZHOU Yali, LI Jing, LU Xilan, BAI Hongwei, SHI Yuhua. Clinical effects of body mass index on ovulation induction treatment with letrozole among women with polycystic ovary syndrome [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(5): 81-85.
[12] ZHANG Lin, LI Jing, WANG Ze, ZHANG Jiangtao, MA Zengxiang, SHI Yuhua. Impact of thyroid-stimulating hormone on blood glucose and serum lipids in patients with polycystic ovary syndrome [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 80-84.
[13] LI Jingbo, LIU Hongbin, JIA Yueyue, WANG Ze, SUN Mei, SHI Yuhua. Expression and clinical significance of microRNA-183 in polycystic ovary syndrome with insulin resistance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 69-74.
[14] JIA Yueyue, LIU Hongbin, LI Jingbo, LI Jing, ZHANG Jiangtao, SUN Mei, SHI Yuhua. Expression of microRNA-200b in granulosa cells of PCOS patients and its significance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 63-68.
[15] YANG Dongzi, MAI Zhuoyao. Features of ovarian reserve and outcomes of assisted reproductive technology in elder patients with PCOS [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 26-32.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd